Taken together, the Americas represent some 60% of the global market, led by the United States with more than 50%. The main medical markets in Latin America are Brazil and Mexico, followed by Argentina.
Unlike the wealthier U.S. market where private insurance dominates the market, 75% of the population in Brazil is covered by the state-run Unified Health System (although only 42% of the country’s healthcare spending is in the public sector). Accordingly, securement markets in Brazil are dominated by use of conventional, low-cost closures (sutures, staples, tapes) dominate the market, while more expensive novel closures (sealants and glues) have relatively modest market shares. The same is true of Argentina, which is still recovering from a severe economic depression in the 1990s. Mexico, the eighth biggest trading market in the world, operates a health care system under which 60%–70% of the population are covered by public insurance schemes. In terms of expenditure on medical products, Mexico occupies a position between that of developed and developing economies, and this is reflected in the shares of the wound closure market represented by premium-priced and commodity product groups.
Nonetheless, growth of conventional closures like sutures, staples and tapes is relatively stagnant in the non-USA Americas compared to growth of advanced securement market.
From "Worldwide Surgical Sealants, Glues and Wound Closure Market, 2009-2013," published by MedMarket Diligence. See report #S175.